Apollo Medical Holdings
Market Cap
US$770.3m
Last Updated
2019/10/17 00:40 UTC
Data Sources
Company Financials +
Executive Summary
Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services.
Snowflake
Fundamentals
High growth potential with adequate balance sheet.
Similar Companies
Share Price & News
How has Apollo Medical Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-1.8%
AMEH
4.6%
US Healthcare
2.3%
US Market
1 Year Return
-16.1%
AMEH
-8.5%
US Healthcare
5.6%
US Market
Return vs Industry: AMEH underperformed the US Healthcare industry which returned -8.5% over the past year.
Return vs Market: AMEH underperformed the US Market which returned 5.6% over the past year.
Shareholder returns
| AMEH | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.8% | 4.6% | 2.3% |
| 30 Day | -27.2% | -0.1% | -1.0% |
| 90 Day | -1.3% | -4.5% | -0.7% |
| 1 Year | -16.1%-16.1% | -7.1%-8.5% | 7.9%5.6% |
| 3 Year | n/a | 31.9%26.5% | 45.6%36.3% |
| 5 Year | n/a | 63.7%53.9% | 65.8%47.6% |
Price Volatility Vs. Market
How volatile is Apollo Medical Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 weeks ago | Simply Wall St
Michael Eng Is The Director of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) And They Just Spent US$41k On Shares1 month ago | Simply Wall St
What Is Apollo Medical Holdings's (NASDAQ:AMEH) P/E Ratio After Its Share Price Rocketed?1 month ago | Simply Wall St
How Does Apollo Medical Holdings's (NASDAQ:AMEH) P/E Compare To Its Industry, After Its Big Share Price Gain?Valuation
Is Apollo Medical Holdings undervalued compared to its fair value and its price relative to the market?
52.87x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Undervalued: Insufficient data to calculate AMEH's fair value to establish if it is undervalued.
Significantly Undervalued: Insufficient data to calculate AMEH's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: AMEH is poor value based on its PE Ratio (52.9x) compared to the Healthcare industry average (20.3x).
PE vs Market: AMEH is poor value based on its PE Ratio (52.9x) compared to the US market (17.7x).
Price to Earnings Growth Ratio
Low PEG Ratio: AMEH is good value based on its PEG Ratio (0.5x)
Price to Book Ratio
PB vs Industry: AMEH is overvalued based on its PB Ratio (2.8x) compared to the US Healthcare industry average (2.5x).
Next Steps
Future Growth
How is Apollo Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
112.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMEH's forecast earnings growth (112% per year) is above the savings rate (2.7%).
Earnings vs Market: AMEH's earnings (112% per year) are forecast to grow faster than the US market (14.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMEH's revenue (20.3% per year) is forecast to grow faster than the US market (7.3% per year).
High Growth Revenue: AMEH's revenue (20.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: Insufficient data to determine if AMEH's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has Apollo Medical Holdings performed over the past 5 years?
18.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: AMEH's earnings have grown by 18.5% per year over the past 5 years.
Accelerating Growth: AMEH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: AMEH had negative earnings growth (-60.1%) over the past year, making it difficult to compare to the Healthcare industry average (5.3%).
Return on Equity
High ROE: AMEH's Return on Equity (11.1%) is considered low.
Return on Assets
ROA vs Industry: AMEH's Return on Assets is below or equal to the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: AMEH has significantly improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is Apollo Medical Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: AMEH's short term assets ($167.6M) exceeds its short term liabilities ($78.3M)
Long Term Liabilities: AMEH's short term assets (167.6M) exceeds its long term liabilities (84.3M)
Debt to Equity History and Analysis
Debt Level: AMEH's debt to equity ratio (11%) is considered satisfactory
Reducing Debt: Insufficient data to determine if AMEH's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AMEH's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: AMEH earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: AMEH has a low level of unsold assets or inventory.
Debt Coverage by Assets: AMEH's debt is covered by short term assets (assets are 3.758420x debt).
Next Steps
Dividend
What is Apollo Medical Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate AMEH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate AMEH's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if AMEH's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AMEH's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AMEH's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of Apollo Medical Holdings's salary, the management and board of directors tenure and is there insider trading?
0.08yrs
Average management tenure
CEO
Kenneth Sim 0
0.08yrs
Tenure
Dr. Kenneth T. Sim, M.D., serves as Co-Chief Executive Officer at Apollo Medical Holdings, Inc. since September 30, 2019. Dr. Simhas been an Executive Chairman of Apollo Medical Holdings, Inc. since Decemb ...
Management Age and Tenure
0.08yrs
Average Tenure
Experienced Management: AMEH's management team is not considered experienced ( 0.1 years average tenure), which suggests a new team.
Board Age and Tenure
1.8yrs
Average Tenure
70.5yo
Average Age
Experienced Board: AMEH's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: AMEH insiders have sold more shares than they have bought in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Senior Key Executive Chief Medical Officer |
| Shares | 84,800 |
| Max Price | US$20.14 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 2,000 |
| Max Price | US$20.28 |
| Entity | Individual |
| Role | Chief Administrative Officer Chief Administrative Officer |
| Shares | 5,000 |
| Max Price | US$15.01 |
| Entity | Individual |
| Role | Member of the Board of Directors President |
| Shares | 17,200 |
| Max Price | US$16.85 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 1,000 |
| Max Price | US$15.97 |
| Entity | Individual |
| Role | Co-Chief Executive Officer Executive Chairman & Co-Chief Executive Officer |
| Shares | 6,000 |
| Max Price | US$16.35 |
| Entity | Individual |
| Shares | 7,521 |
| Max Price | US$14.70 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 100 |
| Max Price | US$16.31 |
| Entity | Individual |
| Role | Chief Financial Officer CFO & Corporate Secretary |
| Shares | 2,040 |
| Max Price | US$14.72 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 10,000 |
| Max Price | US$14.13 |
| Entity | Individual |
| Role | Member of the Board of Directors President |
| Shares | 6,900 |
| Max Price | US$14.64 |
| Entity | Individual |
| Role | Co-Chief Executive Officer Executive Chairman & Co-Chief Executive Officer |
| Shares | 6,996 |
| Max Price | US$14.51 |
| Entity | Individual |
| Role | Senior Key Executive Chief Medical Officer |
| Shares | 85,000 |
| Max Price | US$16.64 |
| Entity | Individual |
| Shares | 35,000 |
| Max Price | US$16.60 |
| Entity | Individual |
| Shares | 50,000 |
| Max Price | US$17.91 |
| Entity | Individual |
| Shares | 50,000 |
| Max Price | US$17.07 |
| Entity | Individual |
| Shares | 40,000 |
| Max Price | US$18.97 |
| Entity | Individual |
| Role | Senior Key Executive Chief Medical Officer |
| Shares | 221,597 |
| Max Price | US$18.56 |
Ownership Breakdown
Management Team
Adrian Vazquez (49yo)
Chief Medical Officer
- Tenure: 0yrs
Thomas Lam (70yo)
President
- Tenure: 1.8yrs
Eric Chin
CFO & Corporate Secretary
- Tenure: 1.3yrs
Kenneth Sim
Executive Chairman & Co-Chief Executive Officer
- Tenure: 0.08yrs
Hing Ang
Chief Operating Officer
- Tenure: 1.8yrs
Albert Young WaiChow
Chief Administrative Officer
- Tenure: 0.08yrs
Brandon Sim
Interim Chief Technology Officer
- Tenure: 0.08yrs
Board Members
Ernest Bates (82yo)
Director
- Tenure: 1.3yrs
Dave Schmidt (71yo)
Director
- Tenure: 1.8yrs
Mark Fawcett (52yo)
Director
- Tenure: 0yrs
John Chiang
Director
- Tenure: 0.8yrs
Thomas Lam (70yo)
President
- Tenure: 1.8yrs
Kenneth Sim
Executive Chairman & Co-Chief Executive Officer
- Tenure: 0.08yrs
Li Yu
Director
- Tenure: 1.8yrs
Mitchell Kitayama
Director
- Tenure: 1.8yrs
Michael Eng
Director
- Tenure: 1.8yrs
Linda Marsh
Director
- Tenure: 0.8yrs
Company Information
Apollo Medical Holdings, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Apollo Medical Holdings, Inc.
- Ticker: AMEH
- Exchange: NasdaqCM
- Founded: 1994
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$770.339m
- Shares outstanding: 50.91m
- Website: https://www.apollomed.net
Number of Employees
Location
- Apollo Medical Holdings, Inc.
- 1668 South Garfield Avenue
- 2nd Floor
- Alhambra
- California
- 91801
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| AMEH | NasdaqCM (Nasdaq Capital Market) | Yes | Common Stock | US | USD | Dec 2017 |
Biography
Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents o ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/17 00:40 |
| End of Day Share Price | 2019/10/16 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.